NASDAQ:XBIO - Nasdaq - US9840156023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
---|---|---|---|---|---|---|---|
Revenue YoY % growth | 1.71M 47.41% | 2.54M 48.54% | 2.5M -1.56% | 2.754M 10.15% | 3.06M 11.11% | 2.55M -16.67% | |
EBITDA YoY % growth | N/A -20.63% | -4.516M 34.89% | N/A -40.04% | -4.386M 30.65% | -8.058M -83.72% | -12.342M -53.16% | |
EBIT YoY % growth | -6.72M -16.87% | -4.516M 32.80% | -3.5M 22.49% | -4.386M -25.31% | -8.058M -83.72% | -12.342M -53.16% | |
Operating Margin | -392.98% | -177.78% | -139.98% | -159.26% | -263.33% | -484.00% | |
EPS YoY % growth | -4.70 -737.79% | -2.75 41.49% | -2.57 6.55% | -2.61 -1.60% | -4.55 -74.22% | -0.44 90.36% |
All data in USD
Q3 / 25 | Q4 / 25 | |
---|---|---|
EPS Q2Q % growth | -0.50 -78.50% | -0.53 22.00% |
Revenue Q2Q % growth | 642.6K 4.62% | 703.8K 8.61% |
EBITDA Q2Q % growth | -816K 46.67% | -918K 57.14% |
EBIT Q2Q % growth | -816K -63.36% | -918K 16.48% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q2 2025 Q2Q % growth | -0.45 45.78% | -0.65 | 0.20 | 31.07% |
Q1 2025 Q2Q % growth | -0.59 24.36% | -0.73 | 0.14 | 19.66% |
Q4 2024 Q2Q % growth | -0.68 11.69% | -0.20 | -0.48 | -233.33% |
Q3 2024 Q2Q % growth | -0.28 59.42% | -0.14 | -0.14 | -96.08% |
Q2 2024 Q2Q % growth | -0.83 -20.29% | -0.85 | 0.02 | 1.96% |
Q1 2024 Q2Q % growth | -0.78 -30.00% | -0.81 | 0.03 | 3.20% |
Q4 2023 Q2Q % growth | -0.77 23.00% | -0.89 | 0.12 | 13.23% |
Q3 2023 Q2Q % growth | -0.69 -15.00% | -1.14 | 0.45 | 39.60% |
Q2 2023 Q2Q % growth | -0.69 63.68% | -1.15 | 0.46 | 40.14% |
Q1 2023 Q2Q % growth | -0.60 50.00% | -1.12 | 0.52 | 46.52% |
Q4 2022 Q2Q % growth | -1.00 -553.59% | -0.92 | -0.08 | -8.93% |
Q3 2022 Q2Q % growth | -0.60 -361.54% | -1.84 | 1.24 | 67.32% |
Q2 2022 Q2Q % growth | -1.90 -1,361.54% | -1.22 | -0.68 | -55.23% |
Q1 2022 Q2Q % growth | -1.20 -700.00% | -1.12 | -0.08 | -6.95% |
Q4 2021 Q2Q % growth | 4.38% | -0.15 | % | |
Q3 2021 Q2Q % growth | -0.13 -148.15% | -0.12 | -0.01 | -6.21% |
Q2 2021 Q2Q % growth | -0.13 13.33% | -0.16 | 0.03 | 20.34% |
Q1 2021 Q2Q % growth | -0.15 21.05% | -0.13 | -0.02 | -13.12% |
Q4 2020 Q2Q % growth | -0.16 20.40% | -0.20 | 0.04 | 21.57% |
Q3 2020 Q2Q % growth | 0.27 | -0.16 | 0.43 | 270.78% |
Q2 2020 Q2Q % growth | -0.15 | -0.22 | 0.07 | 33.16% |
Q1 2020 Q2Q % growth | -0.19 | -0.38 | 0.19 | 49.66% |
Q4 2019 Q2Q % growth | -0.20 | -0.39 | 0.19 | 48.14% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q2 2025 Q2Q % growth | 589.9K -18.79% | 652.8K | -62.9K | -9.64% |
Q1 2025 Q2Q % growth | 593.26K 16.14% | 683.4K | -90.14K | -13.19% |
Q4 2024 Q2Q % growth | 648K -3.57% | 234.6K | 413.4K | 176.21% |
Q3 2024 Q2Q % growth | 614.24K 0.50% | 765K | -150.76K | -19.71% |
Q2 2024 Q2Q % growth | 726.4K 11.58% | 550.8K | 175.6K | 31.88% |
Q1 2024 Q2Q % growth | 510.82K -15.68% | 663K | -152.18K | -22.95% |
Q4 2023 Q2Q % growth | 672K 37.14% | 693.6K | -21.6K | -3.11% |
Q3 2023 Q2Q % growth | 611.17K 49.07% | 489.6K | 121.57K | 24.83% |
Q2 2023 Q2Q % growth | 651.01K 55.00% | 448.8K | 202.21K | 45.06% |
Q1 2023 Q2Q % growth | 605.84K 55.34% | 418.2K | 187.64K | 44.87% |
Q4 2022 Q2Q % growth | 490K 48.48% | 204K | 286K | 140.20% |
Q3 2022 Q2Q % growth | 410K 17.14% | 357K | 53K | 14.85% |
Q2 2022 Q2Q % growth | 420K 44.83% | 346.8K | 73.2K | 21.11% |
Q1 2022 Q2Q % growth | 390K 105.26% | 346.8K | 43.2K | 12.46% |
Q4 2021 Q2Q % growth | 330K 120.00% | 102K | 228K | 223.53% |
Q3 2021 Q2Q % growth | 350K 191.67% | 204K | 146K | 71.57% |
Q2 2021 Q2Q % growth | 290K 163.64% | 193.8K | 96.2K | 49.64% |
Q1 2021 Q2Q % growth | 190K 216.67% | 61.2K | 128.8K | 210.46% |
Q4 2020 Q2Q % growth | 150K 650.00% | 121.89K | 28.11K | 23.06% |
Q3 2020 Q2Q % growth | 120K | 98.94K | 21.06K | 21.29% |
Q2 2020 Q2Q % growth | 110K | 61.2K | 48.8K | 79.74% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | 18.99% | 0% | 20.99% |
Revenue | 0% | -7.25% | 0% | -3.57% |